Loading clinical trials...
Loading clinical trials...
This clinical trial investigated the combined effects of Semaglutide and a fiber supplement (glucomannan, inulin, psyllium) on weight loss in adults with overweight or obesity. Participants, aged 18-6...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
S.LAB (SOLOWAYS)
Collaborators
NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more
NCT04805502 · Pregnancy, Overweight and Obesity
NCT06555393 · High Blood Sugar, High Blood Pressure, and more
NCT06526273 · Type 2 Diabetes, Hypertension, and more
NCT06277232 · Nutrition Poor, Overweight and Obesity, and more
Center of New Medical Technologies
Novosibirsk, Novosibisk Region
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions